Ticker Symbol: HZNQF
Horizon Discovery Group Plc
Exchange: US OTC
Country:
GB
Currency:
USD
Asset
Type: Common Stock
Company Profile
Horizon Discovery Group Plc is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom.
Sector: Health Technology
Industry: Biotechnology
Standard Industrial Classification Code (SIC code): 2833
Address: 8100 Cambridge Research Park
Website: http://horizondiscovery.com/
CEO: Terrence William Pizzie
Tags:
- Biotechnology
- Health Technology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $2.45 - $2.45
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 164214591
Valuation
Market Cap: 40.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A